Antithrombotic agents in cerebral ischaemia

P. M. Dalal, N. K. Mishra, Madhumita Bhattacharjee, Priya Bhat

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


The current evidence suggests that aspirin is treatment of choice when compared to anticoagulants for patients with non-cardioembolic stroke. The usefulness of combination therapy (aspirin vs. with or without warfarin) is still debated. Likewise the combination of Aspirin with clopidogrel has no added advantage (MATCH Trial). However anticoagulant therapy significantly benefits high-risk patients with atrial fibrillation in the elderly subjects whereas aspirin may still be the drug of choice in stroke prevention in low risk group in the younger age. There is dire need for well planned randomized double blind controlled studies to define the role of Antithrombotic agents in "cryptogenic stroke" (PFO/ASD related) antiphospholipid antibody syndrome, arterial dissections and intraluminal clot syndromes. Evaluation and treatment of associated risk factors in all categories needs greater emphasis.

Original languageEnglish
Pages (from-to)555-561
Number of pages7
JournalThe Journal of the Association of Physicians of India
Issue numberJULY
StatePublished - Jul 2006
Externally publishedYes


Dive into the research topics of 'Antithrombotic agents in cerebral ischaemia'. Together they form a unique fingerprint.

Cite this